IRIS, 2016 trial summary    PDF trial summary

A randomised clinical trial investigating the effect of pioglitazone versus placebo in

        Z

NCT00091949    N Engl J Med 2016 Apr 7;374:1321-31  



Studied treatment
Control treatment



Patients
Group sizes-9 / -9



Blindness Inclusion period
Follow-up duration Centers
Lost to FU geographical localisation
Primary endpoint Design



EndpointX1N1X0N0TE95% CI Retinopathy - -9 - -9 no data CVdeath - -9 - -9 no data Nephropathy - -9 - -9 no data all causes death - -9 - -9 no data Microvascular event - -9 - -9 no data fatal and non fatal MI - -9 - -9 no data Hospitalization for heart failure - -9 - -9 no data fatal and non fatal stroke - -9 - -9 no data HbA1c - -9 - -9 no data CV events - -9 - -9 no data0,22,01,0

Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R, Brass LM, Schwartz GG, Adams HP Jr, Berger L, Carolei A, Clark W, Coull B, Ford GA, Kleindorfer D, O'Leary JR, Parsons MW, Ringleb P, Sen S, Sp Pioglitazone after Ischemic Stroke or Transient Ischemic Attack. N Engl J Med 2016 Apr 7;374:1321-31     [PMID: 26886418]   link to pdf   add to Mendeley  

ClinicalTrial.gov record NCT00091949



Registering number NCT00091949 (see trial on clinicaltrials.gov)
Code Name

 

Appears in following systematic reviews: